Antimalarial chemoprophylaxis for forest goers in southeast Asia: an open-label, individually randomised controlled trial

<p><strong>Background:</strong> Malaria in the eastern Greater Mekong subregion has declined to historic lows. Countries in the Greater Mekong subregion are accelerating malaria elimination in the context of increasing antimalarial drug resistance. Infections are now increasingly c...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Tripura, R, von Seidlein, L, Sovannaroth, S, Peto, TJ, Callery, JJ, Sokha, M, Ean, M, Heng, C, Conradis-Jansen, F, Madmanee, W, Peerawaranun, P, Waithira, N, Khonputsa, P, Jongdeepaisal, M, Pongsoipetch, K, Chotthanawathit, P, Soviet, U, Pell, C, Duanguppama, J, Rekol, H, Tarning, J, Imwong, M, Mukaka, M, Dondorp, AM, White, NJ, Maude, RJ
Formaat:	Journal article
Taal:	English
Gepubliceerd in:	Elsevier 2022

Antimalarial chemoprophylaxis for forest goers in southeast Asia: an open-label, individually randomised controlled trial

Gelijkaardige items